Results 41 to 50 of about 53,102 (149)
Nepal Journal of Neuroscience, 2021 Introduction Single burr hole surgery for Chronic subdural hematoma (CSDH) is commonly performed neurosurgical procedure with >90% favorable outcome and less hospital stay. However, sometimes hospital stay may be prolonged due to associated prognostic
Sumit Joshi +4 more
doaj +1 more source
Can drug-induced platelet dysfunction be reversed?
Research and Practice in Thrombosis and HaemostasisAntiplatelet drugs are used for treatment of arterial disease, but side effects include an increased risk of bleeding. For patients with intracerebral hemorrhage, traumatic brain injury, and lower gastrointestinal bleeding, mortality rates are higher for
Suzanne Maynard +2 more
doaj +1 more source
EJVES Short Reports, 2015 : Case: A 73 year old patient with a longstanding history of peripheral artery occlusive disease (PAOD) presented with an acute on chronic progression of symptoms, based on a long occlusion of the superficial femoral artery (SFA), which was treated by ...
S.M.O. Peeters Weem +5 more
doaj +1 more source
Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
Chinese Journal of Contemporary Neurology and Neurosurgery, 2013 Nowadays, antiplatelet drugs are still the routine medication in the acute phase and in secondary prevention of ischemic stroke. Although the clinical effect of classic antiplatelet drugs, such as aspirin and clopidogrel, has been recognized, some ...
Pan LI, Yu-ying ZHOU
doaj
BMC Neurology, 2017 Background Evaluation of secondary stroke prevention in low and middle-income countries remains limited. This study assessed the prescription of secondary preventive drugs among ischemic stroke patients upon hospital discharge in Malaysia and identified ...
Wen Yea Hwong +7 more
doaj +1 more source
The study of price situation on the domestic antiplatelet market
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017 Complex therapy of cardiovascular diseases and their prophylaxis include antiplatelet administration. Considering that in most cases patients with cardiovascular diseases need antiplatelet administration during long time, social and economic availability
Ye. А. Redkina +3 more
doaj +1 more source
A pharmacoeconomic study on cost variation of antiplatelet drugs available in Indian market
National Journal of Physiology, Pharmacy and Pharmacology, 2020 Background: Expenditure spent on pharmaceutical products accounts for a significant percent of the total health-care expenses of any country. Hence, there is a need to prioritize different and sometimes competing health-care interventions or possibly ...
Ainsy Goldlin T J, Prakash M
doaj +1 more source
Arthroplasty Today, 2018 Background: Although studies have supported the utility of perioperative continuation of antiplatelet drugs, vasodilators, and cerebral ameliorators in most procedures, no study compared total volume of blood loss after total knee arthroplasty (TKA) in ...
Sachiyuki Tsukada, MD +1 more
doaj +1 more source
ANTIPLATELET DRUGS IN CARDIOVASCULAR DISEASES
International Journal of Clinical Practice, 2003 SUMMARYPlatelets play a key role in the pathogenesis of atherothrombotic conditions, e.g. acute coronary syndromes, cerebrovascular and peripheral vascular events. Antiplatelet agents interfere with platelet activation and aggregation and, as such, would be expected to modify the natural history of cardiovascular disease.
C, Weston, U, Rao
openaire +2 more sources
Российский кардиологический журнал, 2014 The review provides the current information about the role of antiplatelet therapy in the cardiovascular prevention in patients with coronary artery disease and coronary revascularization.
Yu. I. Grinschtein +2 more
doaj +1 more source